ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Net Income (Continuing Operations) : kr-91.40 Mil (TTM As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is ExpreS2ion Biotech Holding AB Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. ExpreS2ion Biotech Holding AB's Net Income (Continuing Operations) for the three months ended in Dec. 2023 was kr-13.23 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2023 was kr-91.40 Mil.

ExpreS2ion Biotech Holding AB Net Income (Continuing Operations) Historical Data

The historical data trend for ExpreS2ion Biotech Holding AB's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ExpreS2ion Biotech Holding AB Net Income (Continuing Operations) Chart

ExpreS2ion Biotech Holding AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income (Continuing Operations)

Get a 7-Day Free Trial

-17.26

-31.71

-43.93

-118.61

-91.40

ExpreS2ion Biotech Holding AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Income (Continuing Operations)	Get a 7-Day Free Trial															-48.53	-26.31	-30.04	-21.83	-13.23

ExpreS2ion Biotech Holding AB Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-91.40 Mil.

ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

ExpreS2ion Biotech Holding AB Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of ExpreS2ion Biotech Holding AB's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

5JD:Germany

Address

c/o Mindpark, Ronnowsgatan 8c, Helsingborg, SWE, S-252 25

Website

https://www.expres2ionbio.com

ExpreS2ion Biotech Holding AB has developed a technology platform, ExpreS2, for fast and efficient non-clinical development and production of complex proteins for new vaccines and diagnostics. ExpreS2 is regulatorily validated for clinical supply. The platform includes functionally modified glycosylation variants for enhanced immunogenicity and pharmacokinetics. The company has produced more than 500 proteins and virus-like particles (VLPs) in collaboration with research institutions and companies.

ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Headlines

No Headlines